CLCN2

Chr 3ADAR

chloride voltage-gated channel 2

Also known as: CIC-2, CLC2, ECA2, ECA3, EGI11, EGI3, EGMA, EJM6

This gene encodes a voltage-gated chloride channel. The encoded protein is a transmembrane protein that maintains chloride ion homeostasis in various cells. Defects in this gene may be a cause of certain epilepsies. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]

Primary Disease Associations & Inheritance

{Epilepsy, idiopathic generalized, susceptibility to, 11}MIM #607628
AD
{Epilepsy, juvenile absence, susceptibility to, 2}MIM #607628
AD
{Epilepsy, juvenile myoclonic, susceptibility to, 8}MIM #607628
AD
Hyperaldosteronism, familial, type IIMIM #605635
AD
Leukoencephalopathy with ataxiaMIM #615651
AR
UniProtJuvenile absence epilepsy 2
746
ClinVar variants
20
Pathogenic / LP
0.00
pLI score
0
Active trials
Clinical SummaryCLCN2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
20 Pathogenic / Likely Pathogenic· 131 VUS of 746 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.77LOEUF
pLI 0.000
Z-score 2.83
OE 0.55 (0.410.77)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
0.65Z-score
OE missense 0.92 (0.850.99)
494 obs / 536.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.55 (0.410.77)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.92 (0.850.99)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.09
01.21.6
LoF obs/exp: 26 / 46.9Missense obs/exp: 494 / 536.6Syn Z: -0.97

ClinVar Variant Classifications

746 submitted variants in ClinVar

Classification Summary

Pathogenic12
Likely Pathogenic8
VUS131
Likely Benign45
Benign2
Conflicting2
12
Pathogenic
8
Likely Pathogenic
131
VUS
45
Likely Benign
2
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
0
8
0
12
Likely Pathogenic
5
0
3
0
8
VUS
2
112
11
6
131
Likely Benign
0
2
23
20
45
Benign
0
0
2
0
2
Conflicting
2
Total111144726200

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CLCN2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

CLCN2-related leukoencephalopathy with ataxia

definitive
ARLoss Of FunctionAbsent Gene Product
Eye
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

{Epilepsy, idiopathic generalized, susceptibility to, 11}

MIM #607628

Molecular basis of disorder known

Autosomal dominant

{Epilepsy, juvenile absence, susceptibility to, 2}

MIM #607628

Molecular basis of disorder known

Autosomal dominant

{Epilepsy, juvenile myoclonic, susceptibility to, 8}

MIM #607628

Molecular basis of disorder known

Autosomal dominant

Hyperaldosteronism, familial, type II

MIM #605635

Molecular basis of disorder known

Autosomal dominant

Leukoencephalopathy with ataxia

MIM #615651

Molecular basis of disorder known

Autosomal recessive
Clinical Literature
Landmark / reviewRecent case evidence

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →